Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bunting

Showing results (131-140 of 149) with videos related to

Pageof 15
Sort By:
The American Journal of Pathology|December 1, 1995
Time course of increased cellular proliferation in collateral arteries after administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiencyS Takeshita, S T Rossow, M Kearney, et al.
Circulation|March 1, 1991
Kistrin, a polypeptide platelet GPIIb/IIIa receptor antagonist, enhances and sustains coronary arterial thrombolysis with recombinant tissue-type plasminogen activator in a canine preparationT Yasuda, H K Gold, R C Leinbach, et al.
Cardiovascular Research|January 20, 1999
VEGF administration in chronic myocardial ischemia in pigsJ J Lopez, R J Laham, A Stamler, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1990
Platelet glycoprotein IIb-IIIa protein antagonists from snake venoms: evidence for a family of platelet-aggregation inhibitorsM S Dennis, W J Henzel, R M Pitti, et al.
Blood|November 14, 1997
Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietinS Bunting, R Widmer, T Lipari, et al.
Journal of the American College of Cardiology|February 24, 2001
Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemiaK Sato, T Wu, R J Laham, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2001
Vascular endothelial growth factor-mediated endothelium-dependent relaxation is blunted in spontaneously hypertensive ratsM H Liu, H K Jin, H S Floten, et al.
Thrombosis and Haemostasis|February 12, 1998
Pharmacokinetics, pharmacodynamics and tolerability of a potent, non-peptidic, GP IIb/IIIa receptor antagonist following multiple oral administrations of a prodrug formC J Refino, N B Modi, S Bullens, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 13, 2001
Dobutamine stress cine-MRI of cardiac function in the hearts of adult cardiomyocyte-specific VEGF knockout miceS P Williams, H P Gerber, F J Giordano, et al.
Journal of Medicinal Chemistry|May 29, 1992
Cyclic RGD peptide analogues as antiplatelet antithromboticsP L Barker, S Bullens, S Bunting, et al.
Pageof 15

Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
The American Journal of Pathology|December 1, 1995
Time course of increased cellular proliferation in collateral arteries after administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiencyS Takeshita, S T Rossow, M Kearney, et al.
Circulation|March 1, 1991
Kistrin, a polypeptide platelet GPIIb/IIIa receptor antagonist, enhances and sustains coronary arterial thrombolysis with recombinant tissue-type plasminogen activator in a canine preparationT Yasuda, H K Gold, R C Leinbach, et al.
Cardiovascular Research|January 20, 1999
VEGF administration in chronic myocardial ischemia in pigsJ J Lopez, R J Laham, A Stamler, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1990
Platelet glycoprotein IIb-IIIa protein antagonists from snake venoms: evidence for a family of platelet-aggregation inhibitorsM S Dennis, W J Henzel, R M Pitti, et al.
Blood|November 14, 1997
Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietinS Bunting, R Widmer, T Lipari, et al.
Journal of the American College of Cardiology|February 24, 2001
Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemiaK Sato, T Wu, R J Laham, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2001
Vascular endothelial growth factor-mediated endothelium-dependent relaxation is blunted in spontaneously hypertensive ratsM H Liu, H K Jin, H S Floten, et al.
Thrombosis and Haemostasis|February 12, 1998
Pharmacokinetics, pharmacodynamics and tolerability of a potent, non-peptidic, GP IIb/IIIa receptor antagonist following multiple oral administrations of a prodrug formC J Refino, N B Modi, S Bullens, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 13, 2001
Dobutamine stress cine-MRI of cardiac function in the hearts of adult cardiomyocyte-specific VEGF knockout miceS P Williams, H P Gerber, F J Giordano, et al.
Journal of Medicinal Chemistry|May 29, 1992
Cyclic RGD peptide analogues as antiplatelet antithromboticsP L Barker, S Bullens, S Bunting, et al.
Pageof 15